Two Sigma Advisers
BDTX icon

Two Sigma Advisers’s Black Diamond Therapeutics BDTX Stock Holding History

Two Sigma Advisers’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,600
Closed -$69.5K – 259
2025
Q4 		$69.5K Buy
28,600
+14,600
+104% +$51.7K ﹤0.01% 2258
2025
Q3 		$53.1K Buy
+14,000
New +$41K ﹤0.01% 2267
2024
Q2 		– Sell
-96,300
Closed -$488K – 2446
2024
Q1 		$488K Sell
96,300
-6,600
-6% -$26.6K ﹤0.01% 1880
2023
Q4 		$289K Buy
102,900
+74,700
+265% +$175K ﹤0.01% 2113
2023
Q3 		$80.9K Buy
28,200
+15,400
+120% +$56.7K ﹤0.01% 2237
2023
Q2 		$64.6K Sell
12,800
-163,100
-93% -$333K ﹤0.01% 2247
2023
Q1 		$332K Sell
175,900
-36,600
-17% -$84.1K ﹤0.01% 2104
2022
Q4 		$383K Sell
212,500
-2,100
-1% -$3.78K ﹤0.01% 1984
2022
Q3 		$363K Sell
214,600
-53,500
-20% -$165K ﹤0.01% 1976
2022
Q2 		$660K Sell
268,100
-27,500
-9% -$63.9K ﹤0.01% 1796
2022
Q1 		$819K Buy
295,600
+97,100
+49% +$355K ﹤0.01% 1749
2021
Q4 		$1.06M Buy
198,500
+17,200
+9% +$120K ﹤0.01% 1538
2021
Q3 		$1.53M Buy
181,300
+97,100
+115% +$959K ﹤0.01% 1400
2021
Q2 		$1.03M Buy
84,200
+41,400
+97% +$818K ﹤0.01% 1620
2021
Q1 		$1.04M Buy
42,800
+11,000
+35% +$297K ﹤0.01% 1634
2020
Q4 		$1.02M Buy
+31,800
New +$1.04M ﹤0.01% 1560

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Advisers's BDTX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Black Diamond Therapeutics (BDTX) in Q1 2026, closing a stake of 28,600 shares — an estimated $69.5K sold.

Two Sigma Advisers first reported a position in BDTX in Q4 2020 and held it in 16 quarters. The position peaked at $1.53M in Q3 2021. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Black Diamond Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 28,600 Black Diamond Therapeutics shares in Q1 2026, an estimated $69.5K.
  • Two Sigma Advisers first reported a position in Black Diamond Therapeutics in Q4 2020 and held it in 16 quarters.
  • Two Sigma Advisers's Black Diamond Therapeutics position peaked at $1.53M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.